BNY Mellon Global Equity Inc GBP W Inc
Pricing frequency
Daily
Dealing cut off time
10:45
Type
OEIC
Yield
2.61%
NAV
£2.9674
Income frequency
Quarterly
Ongoing charge
0.86%
Latest actual NAV date
13-11-2026
ISIN
IE00B90DMY92
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| BNY Mellon US Dollar Liquidity Adv Inc | 3.49 |
| Gilead Sciences Inc | 2.87 |
| AIA Group Ltd | 2.60 |
| Texas Instruments Inc | 2.58 |
| UnitedHealth Group Inc | 2.41 |
| GSK PLC | 2.36 |
| Elevance Health Inc | 2.33 |
| Smurfit WestRock PLC | 2.24 |
| Starbucks Corp | 2.21 |
| AstraZeneca PLC | 2.15 |
Investment objective
The objective of the Sub-Fund is to aim to generate annual distributions and to achieve long-term capital growth by investing predominantly in equity and equity-related global securities.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.